Concepedia

Matthew Sims

MS

Statistics

Publications

33

Citations

1.7K

H-Index

23

Active since

1991

Affiliations

Oakland University(Current)

Beaumont Health

Beaumont Hospital, Royal Oak

Emory University

University of California, Davis

Matthew Sims is an author at Oakland University specializing in infectious diseases, medical microbiology, and microbiology.

ORCID

Publications per year

1991–2024

33

Publications

33

Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections

Matthew Sims, Valeri Mariyanovski, Patrick McLeroth et al. · Journal of Antimicrobial Chemotherapy · 2017 · 161 citations · Full text

, , +13

The Emperor’s New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With Methicillin-resistant Staphylococcus aureus Bloodstream Infections (PROVIDE)

Thomas P. Lodise, Susan L. Rosenkranz, Matthew Finnemeyer et al. · Clinical Infectious Diseases · 2019 · 160 citations · Full text

, , +17

Bile salt hydrolase acyltransferase activity expands bile acid diversity

Douglas V. Guzior, Maxwell Okros, Madison Shivel et al. · Nature · 2024 · 152 citations

, , +14

Colistin Monotherapy versus Combination Therapy for Carbapenem-Resistant Organisms

Keith S. Kaye, Dror Marchaim, Visanu Thamlikitkul et al. · NEJM Evidence · 2022 · 143 citations · Full text

, , +17

Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019

Richard M. Burwick, Sigal Yawetz, Kathryn E. Stephenson et al. · Clinical Infectious Diseases · 2020 · 120 citations · Full text

, , +9

1–5 of 33